Life Sciences Blog

Q&A With Drinker Biddle’s Robyn Shapiro

Posted on July 5th, by Michael Shapiro-Barr

Robyn Shapiro was recently interviewed by Law360 Life Sciences:

Read More

Michael Shapiro-Barr

Michael Shapiro-Barr

Health Group Analyst at Drinker Biddle & Reath LLP
Michael Shapiro-Barr is an Analyst in our Health Care Practice Group. His authored contributions to the blog are derived from his own experiences and perspectives on the life sciences industry. He is not a licensed attorney and his writings should not be viewed as legal advice.
Michael Shapiro-Barr

@lifesciencesnow

Follow @lifesciencesnow


Leave a Reply

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Media Quotes

  • Mercedes Meyer, a patent lawyer with the firm Drinker Biddle in Washington, D.C., said the Supreme Court’s failure to provide “bright-line guidance”—a ruling that would settle once-and-for all whether patent settlements are legal or not—means there’s “really no difference now than what was going on.” Mercedes Meyer
    CNBC: High Court Allows FTC to Challenge 'Pay-to-Delay' Generics

From the Blog

23 Skidoo – Genomes, Gamesmanship and the First Amendment

On November 22, 2013, the Inquisition collided with the Internet.  On that date, the Food and Drug Administration issued a Warning Letter threatening 23andMe,...

FDA’s Warning Letter to 23andMe: Ethical and Legal Issues

The FDA’s warning letter to 23andMe, the maker of mail-order genetic tests, highlights the challenging legal and ethical issues posed by such products.  While...

FDA Final Guidance on Mobile Medical Applications

Summary

On September 23, 2013, the FDA issued a guidance (“Final Guidance”) explaining how medical device regulations will be applied to medical mobile applications (MMAs)....

%d bloggers like this: